Keisuke Kodama

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersAutoimmunityImmunogenetics (incl. genetic immunology)Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Clinicopathological Differences in HER2 Immunohistochemical Expression Between Low-Grade Endometrial Cancer with p53-Abnormal Expression and High-Grade Endometrial Cancer.

|Jul 29, 2025
Secondary Adrenal Insufficiency Due to Isolated ACTH Deficiency Induced by Pembrolizumab: A Report of Two Cases of Uterine Endometrial Cancer.

Ichiro Onoyama, Minoru Kawakami, Kazuhisa Hachisuga

|Mar 28, 2025
Low-Grade Endometrial Cancer with Abnormal p53 Expression as a Separate Clinical Entity: Insights from RNA Sequencing and Immunohistochemistry.

Kazuhisa Hachisuga, Minoru Kawakami, Hiroshi Tomonobe

|Aug 30, 2023
Development of novel tracers for sentinel node identification in cervical cancer.

Keisuke Kodama, Chuya Tateishi, Tsuyoshi Oda

|Oct 18, 2022
Tumor-derived ARHGAP35 mutations enhance the Gα13-Rho signaling axis in human endometrial cancer.

Hiroshi Yagi, Ichiro Onoyama, Kazuo Asanoma

|Nov 14, 2019
Retrospective analysis of treatment and prognosis for uterine leiomyosarcoma: 10-year experience of a single institute.

Keisuke Kodama, Kenzo Sonoda, Masako Kijima

Pageof 1

Frequent Collaborators

3 joint publications

Ichiro Onoyama

2 joint publications

Hideaki Yahata

2 joint publications

Kazuhisa Hachisuga

2 joint publications

Kazuo Asanoma